Next, a RNA binding protein immunoprecipitation (RIP) assay using the c‐Src antibody followed by qRT‐PCR confirmed the binding of c‐Src and LIST in both lung cancer and melanoma cells (Figure 1D). The gene discussed is SRC; the disease is lung carcinoma.